Timeline
Timothée Bruel
Group Leader
13 Dec 2023
14 Jun 2023
publication
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
Read more01 Jun 2023
publication
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.
Read more14 Feb 2023
publication
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
Read more24 Jan 2023
17 Nov 2022
publication
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.
Read more05 Oct 2022
publication
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.
Read more01 Sep 2022
publication
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Read more27 Aug 2022
08 Jul 2022
publication
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination.
Read more04 Jul 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Read more17 Jun 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Read more01 Jun 2022
publication
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.
Read more04 May 2022
publication
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
Read more12 Mar 2022
publication
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
Read more02 Feb 2022
publication
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells.
Read more01 Feb 2022
01 Jan 2022
publication
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Read more01 Nov 2021
publication
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.
Read more17 Sep 2021
publication
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
Read more01 Sep 2021
publication
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Read more18 Aug 2021
01 Aug 2021
publication
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Read more22 Jul 2021
news
SARS-CoV-2 : induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
Read more08 Jul 2021
08 Jun 2021
news
Covid-19, un an après : persistance des anticorps protecteurs et réduction significative du risque de réinfection
Read more18 May 2021
publication
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Read more01 Apr 2021
publication
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020
Read more01 Jan 2021
01 Dec 2020
02 Sep 2020
publication
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Read more01 Sep 2020
publication
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.
Read more05 Feb 2020
publication
Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.
Read more15 Oct 2019
01 Jun 2019
publication
Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice.
Read more01 Aug 2018
23 Feb 2018
publication
Correction: Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection.
Read more13 Oct 2017
publication
HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels
Read more14 Jun 2017
publication
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.
Read more01 May 2017
15 Mar 2017
publication
Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
Read more15 Mar 2017
publication
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Read more25 Jan 2017
10 Oct 2016
publication
CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge
Read more12 Sep 2016
03 Mar 2016
03 Mar 2016
01 Jan 2016
publication
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.
Read more01 Jul 2015
11 May 2015
14 Jan 2015
publication
Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses
Read more26 Nov 2014
30 Jan 2014
publication
Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques
Read more12 Jan 2012
publication
Porcine colon explants in the study of innate immune response to Entamoeba histolytica
Read more21 Dec 2011
13 Apr 2010
publication
Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy
Read more06 Jan 2010
publication